USTEKINUMAB IS SUPERIOR IN TREATMENT PERSISTENCE AND COLECTOMY-FREE SURVIVAL AMONG SEQUENTIAL BIOLOGICAL THERAPIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF – PRELIMINARY DATA OF A RETROSPECTIVE, MULTICENTRE STUDY

Bernadett Farkas  1     Mariann Borsos  2     Tamás Resál  2     Péter Bacsur  2     Anita Balint  2     Zoltán Szepes  2     Renáta Bor  2     Anna Fabian  2     Edoardo Vincenzo Savarino  3, 4     Luisa Bertin  3, 4     Pal Miheller  5     Fruzsina Vilmos  5     Jimmy K. Limdi  6     Karishma Sethi  6     Fabiana Castiglione  7     Fabiana Castiglione  7     Milan Lukas  8     Nitsan Maharshak  9, 10     Galia Berman  9, 10     Georgios Michalopoulos  11     Davide Giuseppe Ribaldone  12     Anna Kagramanova  13, 14     Elena Chashkova  15, 16     Tamás Molnár  16     Klaudia Farkas  16    
1 Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary
2 AdWare Research, Balatonfüred, Hungary
3 University of Padua, Padua, Italy
4 Azienda Ospedale Università of Padua, Padua, Italy
5 Semmelweis University, Budapest, Hungary
6 The Northern Care Alliance Hospitals NHS Foundation Trust, Manchester, United Kingdom
7 University of Naples Federico II, Naples, Italy
8 ISCARE IVF Clinical Center Českomoravská, Prague, Prague, Czechia
9 Tel Aviv University, Tel Aviv, Israel
10 Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
11 General Hospital of Athens "G. Gennimatas", Athens, Greece
12 University of Turin, Turin, Italy
13 Moscow Clinical Scientific Center named after A. S. Loginov, Moscow, Russian Federation
14 Research Institute of Health Organization and Medical Management, Moscow, Russian Federation
15 Federal Scientific Center of Surgery and Traumatology, Irkutsk, Russian Federation
16 Irkutsk Regional Hospital, Irkutsk, Russian Federation

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing